August 30, 2016 1:48 AM ET


Company Overview of EOS (Ethical Oncology Science) S.p.A.

Company Overview

EOS (Ethical Oncology Science) S.p.A. develops targeted medicines to treat cancer. It is primarily involved in the development of Lucitanib, an oral small-molecule tyrosine kinase inhibitor that is in Phase I/II development to prevent the development of new blood vessels essential for tumor growth and to interfere with tumor growth in certain FGF-dependent malignancies. The company was founded in 2006 and is based in Milan, Italy. As of November 19, 2013, EOS (Ethical Oncology Science) S.p.A. operates as a subsidiary of Clovis Oncology, Inc.

Via Monte di Pietà n.1/A

Milan, MI 20121


Founded in 2006


39 02 87 39 16 08


39 02 87 39 16 17

Key Executives for EOS (Ethical Oncology Science) S.p.A.

Co-Founder, Chairman of the Board and Chief Executive Officer
Age: 63
Age: 57
Co-Founder and Vice President of Operations
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
AdriaCell Srl Europe
AEB SPA Europe
APAvadis Biotechnologies Europe
Arterra Bioscience s.r.l. Europe
Axxam SpA Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact EOS (Ethical Oncology Science) S.p.A., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at